Desjardins Global Asset Management Inc. trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 42.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,724 shares of the medical equipment provider’s stock after selling 1,293 shares during the quarter. Desjardins Global Asset Management Inc.’s holdings in Intuitive Surgical were worth $582,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. OFI Invest Asset Management purchased a new stake in shares of Intuitive Surgical in the third quarter valued at about $25,000. Baystate Wealth Management LLC raised its position in shares of Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the period. Headinvest LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $28,000. Stone House Investment Management LLC raised its position in shares of Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the period. Finally, Householder Group Estate & Retirement Specialist LLC acquired a new stake in Intuitive Surgical during the third quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the sale, the vice president now owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 in the last quarter. 0.90% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Research Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Intuitive Surgical stock opened at $374.17 on Thursday. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The business has a fifty day moving average of $387.56 and a two-hundred day moving average of $342.39. The company has a market cap of $132.62 billion, a P/E ratio of 74.39, a price-to-earnings-growth ratio of 5.88 and a beta of 1.36.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. The firm had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.89 billion. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. Intuitive Surgical’s revenue was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Election Stocks: How Elections Affect the Stock Market
- Planet Labs Soars Fueled by AI Data Demand
- How is Compound Interest Calculated?
- These are the Top 4 Stocks for Buybacks in 2024
- Manufacturing Stocks Investing
- United Airlines Soars on Earnings Beat
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.